暴露于阿片类药物作为一种潜在的风险因素,在没有暴露于抗微生物药物的情况下,对抗万科胺耐药性肠球菌的殖民化
Parvathi Radhakrishnan1, Joao F G Monteiro2, David Dombrovsky3
1Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, Providence, RI.
暴露于阿片类药物与具有更高风险的旺科米辛耐药性肠球菌殖民有关. 感染预防策略应考虑针对暴露于阿片类药物的患者,以制这些耐药细菌的传播.
科学领域:
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
- 流行病学 流行病学
背景情况:
- 抗菌剂的使用是众所周知的风险因素,用于抗万科胺素耐药性肠球菌 (VRE) 殖民.
- 新出现的证据表明,非抗菌药物也可能增加VRE风险.
- 了解非抗微生物风险因素对于感染控制至关重要.
研究的目的:
- 为了确定与VRE直肠殖民相关的特定非抗菌药物.
- 调查阿片类药物暴露与VRE殖民之间的关联.
主要方法:
- 采用了一种匹配的病例控制研究设计.
- 病例 (VRE殖民) 和对照 (非殖民) 是从没有最近接触抗菌素的患者中选择的.
- 关于非抗微生物药物暴露的数据是从电子医疗记录中提取的.
主要成果:
- 在4.8%的入院者中检测到抗万科胺素的肠球菌殖民.
- 片暴露被确定为VRE殖民的唯一独立风险因素.
- 暴露于阿片类药物的患者对VRE殖民的调整后几率比为3.8.
结论:
- 暴露于阿片类药物是抗万科米辛耐药性肠球菌殖民的重要危险因素.
- 感染预防工作应考虑针对暴露于阿片类药物的个体.
- 进一步的研究可能会阐明将阿片类药物与VRE获取联系在一起的机制.
更多相关视频
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
09:44Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
相关概念视频
Development of Antibiotic Resistance
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Antimicrobial Effectiveness
Opioid Analgesics: Morphine and Other Natural Cogeners
